Assessing Patient Risk, Benefit, and Outcomes in Drug Development: Insights From Afatinib Clinical Trials Across Diverse Cancer Indications.
Saved in:
| Title: | Assessing Patient Risk, Benefit, and Outcomes in Drug Development: Insights From Afatinib Clinical Trials Across Diverse Cancer Indications. |
|---|---|
| Authors: | Hunter Hall, Rafe1 (AUTHOR) rafe.hall@okstate.edu, Wright, Carson L.1 (AUTHOR), Hughes, Griffin K.1 (AUTHOR), Peña, Andriana M.1 (AUTHOR), Ladd, Chase1 (AUTHOR), Gardner, Brooke1 (AUTHOR), McIntire, Ryan1 (AUTHOR), Ferrell, Matt2 (AUTHOR), Rubenstein, Jane3 (AUTHOR), Tuia, Jordan4 (AUTHOR), Haslam, Alyson4 (AUTHOR), Prasad, Vinay4 (AUTHOR), Vassar, Matt1,5 (AUTHOR) |
| Source: | Clinical Therapeutics. Jun2024, Vol. 46 Issue 6, pe107-e113. 7p. |
| Database: | Academic Search Ultimate |
| ISSN: | 01492918 |
|---|---|
| DOI: | 10.1016/j.clinthera.2024.04.006 |
